Health Technology and AI News

YARDLY, PA–(Marketwire – August 17, 2010) –  Xyntek, Inc., a global leader in IT, automation and compliance solutions, today announces XyNexus™ Healthcare Integration Service, the consolidation of its healthcare IT services that address healthcare information technology (HIT) integration and development aspects, as well as electronic healthcare records (EHR) infrastructures. XyNexus™ is expected to be especially attractive to customers in pursuit of ARRA funding for implementation of Meaningful Use requirements.

The XyNexus™ Healthcare Integration Service team has the expertise to deliver on complex integration requirements involved in HIT planning, assessment, selection, implementation, roll-out, migration, and support of multiple healthcare information solutions as well as healthcare information exchanges (HIE).

“Our XyNexus™ Healthcare Integration Service methodology combines an ideal balance of tools, talents, techniques, and cost management. Healthcare IT organizations that are interested in creating and maintaining a dynamic HIT infrastructure have a reliable partner in Xyntek,” said Mac Hashemian, P.E., President and Chief Executive Officer of Xyntek Inc.

XyNexus™ Healthcare Integration Service manages such applications as:

• Connectivity — Internal and External Systems
• Data Migration — including analysis, definition, and optimization of requirements and system architecture
• Healthcare Enterprise Application Integration
• Healthcare Information Exchange
• Laboratory Information Management
• Regulatory Compliance Management
• System-to-System Messaging / Brokering
• Trading Partner Management
• Transaction Processing
• System Migration (ICD9 to ICD10)
• User Authentication using Biometrics

Hospitals and medical providers rely on Xyntek’s advanced techniques and experienced staff to provide reliable and optimized integration services for the entire HIT lifecycle to ensure that they have well-designed, efficiently optimized technical environments. XyNexus™ Healthcare Integration Service implements technical excellence to ensure HIT implementations for hospitals and provider organizations are successful. Xyntek prides itself on improving healthcare processes by integrating solutions into existing and optimized workflows.

About Xyntek

Xyntek, a global leader in IT, Automation and Compliance solutions, has had its focus on healthcare information technology since its inception in 1986. Its veteran team of consultants have extensive healthcare information technology experience and provide advanced integration solutions for organizations focused on gaining visibility and access to data, working within aggressive timelines, internalizing healthcare processes and operations using external resources, and companies looking to integrate and consolidate data from multiple service providers and sources. Xyntek’s business is based on providing high-end technical services and solutions that allow customers to maximize the benefits of IT and Automation technologies, while adhering to compliance mandates. For more information, visit www.xyntekinc.com.

Click here to see all recent news from this company

INDIANAPOLIS, IN–(Marketwire – August 16, 2010) – iSALUS Healthcare, one of the country’s top web-based electronic medical records (EMR-EHR) software and medical practice management software companies that serves small and medium sized physician practices, today announced a newly formed strategic partnership with the Indianapolis Medical Society (IMS). Through this exclusive endorsement, iSALUS will offer discounted electronic medical records (EMR-EHR) and practice management software subscriptions to more than 2,000 IMS members.

As part of the strategic partnership, iSALUS will offer Indianapolis Medical Society members a pre-negotiated discount for subscriptions to its entire suite of services. These include medical office and practice management software (billing, collections, scheduling, rounds, dictation, charge capture, automated workflow) and electronic medical and health records software (electronic charting, lab interfaces, e-prescribing, automated letters, integrated faxing and document management technology). In addition to software, iSALUS also will provide IMS members with localized training, technical support and customer service.

“The Indianapolis Medical Society is pleased to strengthen our relationship with iSALUS. The company has demonstrated proven leadership in EMR-EHR and practice management software. One of our goals as an organization is to continue to offer practice enhancement opportunities to our physician members; this partnership allows us to do just that,” said John C. Ellis, MD. “Additionally, iSALUS allows our members to purchase individual modules for their medical practices, making the transition to EMR-EHR technology as simple or as diverse as a member requires. We have hands-on experience as to how well the iSALUS EMR-EHR software works since we have used it since 2004 for the IMS Foundation’s Project Health, our outreach initiative for the uninsured residents of Marion County.”

The Indianapolis (Marion County) Medical Society was founded in 1848 and has more than 2,100 members representing approximately 67 percent of the physicians in the greater Indianapolis area. It is a professional membership organization for licensed Doctors of Medicine and Doctors of Osteopathy. The IMS is a component of the Indiana State Medical Association and the American Medical Association. For more information, please visit: www.imsonline.org.

“iSALUS has been an associate member of the Indianapolis Medical Society since 2003,” commented Michael Hall, president and founder of iSALUS Healthcare. “We are proud to contribute to the advancement of the medical industry and to IMS’ members’ success. Our EMR-EHR and practice management software is ideal for IMS’ membership base which is comprised of primarily small to mid-sized physician practices. Through this partnership we will be able to help members achieve Meaningful Use of electronic health and medical records (EMR-EHR), as well as increase the efficiency of their practices and improve patient care.”

About iSALUS Healthcare
Founded in 2000 and headquartered in Indianapolis, iSALUS Healthcare offers web-based, mobile-optimized EMR-EHR and practice management software solutions exclusively for small to medium sized physician practices, healthcare offices and medical clinics. Its proven suite of easy-to-learn and easy-to-use applications is accessible from any Internet connection and provided at an affordable monthly fee. iSALUS includes unlimited technical support and customer service with all of its software subscriptions. Throughout its history, the company has served thousands of doctors and practice managers across the country. For more information, please visit www.isalushealthcare.com or call 888.280.6678.

INDIANAPOLIS, IN–(Marketwire – August 9, 2010) – Indianapolis-headquartered iSALUS Healthcare was recently selected by Indiana Health Information Technology Extension Center (I-HITEC), as a collaborative statewide initiative led by Purdue University, as an electronic medical records (EMR) preferred software partner. This partnership and endorsement allows iSALUS to serve Indiana’s healthcare community as part of a federal stimulus program to implement EMR software systems.

“The entire team at iSALUS has a vested and personal interest in being chosen as a preferred software provider,” said Michael Hall, president and founder of iSALUS Healthcare. “These are the doctors we trust to take care of our families, and we are honored to be chosen to help them provide the very best care to all of their patients.”

iSALUS was selected by I-HITEC from among hundreds of EMR software firms. The company was chosen based on its ability to assist healthcare providers in implementing electronic medical records, allowing them to qualify for federal stimulus money, a proven technology platform, previous experience with small to medium size healthcare practices, ability to quickly and efficiently implement a large number of new providers, and affordable pricing. Through this partnership, iSALUS and I-HITEC will provide Indiana healthcare providers with a full electronic medical records solution, education, training, implementation, technical and customer support.

“The Indiana Health Information Technology Extension Center is tasked with helping 2,200 Indiana primary care providers (PCPs) achieve Meaningful Use of electronic health record technology by 2012,” said Monica Arrowsmith, I-HITEC’s director. “We are confident we can reach this ambitious goal in partnership with iSALUS Healthcare as one of our certified EMR software partners. Together we will bring understandable, implementable and affordable EMR solutions to Indiana’s healthcare community.”

About iSALUS Healthcare
Founded in 2000 and headquartered in Indianapolis, iSALUS Healthcare offers web-based, mobile-optimized EMR and practice management software solutions for small to medium sized physician practices, healthcare offices and medical clinics. Its proven suite of easy-to-learn and easy-to-use applications is accessible from any Internet connection and provided at an affordable monthly fee. iSALUS includes unlimited technical support and customer service with all of its software subscriptions. Throughout its history, the company has served thousands of doctors and practice managers across the country. For more information, visit www.isalushealthcare.com or call 888.280.6678.

About Indiana Health Information Technology Extension Center (I-HITEC)
Indiana Health Information Technology Extension Center (I-HITEC) is a federally-designated state-chartered non-profit led by Purdue University. The organization was formed as a result of the 2009 federal Health Information Technology for Economic and Clinical Health Act and is funded through a four-year, $12 million grant. I-HITEC provides subsidized EHR adoption assistance, Meaningful Use coaching and discounted EHR products and services to Indiana’s small physician practices, public or critical access hospitals, community health centers or rural health clinics as well as other medical settings that serve the uninsured, underinsured, underserved or other at-risk populations. I-HITEC is tasked with educating and helping these entities transition from traditional, paper-based electronic health record management systems to federally-mandated electronic health record (EHR) technology. This initiative benefits Indiana through improvements to the state’s existing health information technology delivery system which will ultimately improve patient outcomes and reduce healthcare costs. To receive reimbursement from the federal stimulus program, Indiana’s healthcare providers must achieve and prove Meaningful Use of EHR software. I-HITEC plays a critical role in this process. For more information about I-HITEC, please visit www.switch.purdue.edu or call (765) 496-1911.

MOUNTAINSIDE, NJ–(Marketwire – August 6, 2010) –  PROTEONOMIX, INC. (OTCBB: PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, announced today that it has formed a new subsidiary called X Gen Medical LLC, a Nevis Virgin Island entity. X Gen Medical has been established with the intention of conducting business in the global medical marketplace. Proteonomix plans on utilizing X Gen Medical to serve as a platform for joint ventures with medical facilities worldwide. It is anticipated that new relationships formed with X Gen Medical will create medical facilities capable of not just attracting treatments locally, but also acting as hubs for medical tourism. Medical tourism is constantly on the rise and anticipated to continue to grow substantially due to current high costs of health care for certain procedures and improvements in both technology and standards of care in many countries.

Mr. Michael Cohen, Chairman and CEO of Proteonomix, stated, “We have been in negotiations with several groups, specifically in the Middle East and Europe, to establish Proteonomix Regenerative Translational Medicine Institute (“PRTMI”) medical facilities in those regions. The negotiations have reached the level whereby the establishment of a separate subsidiary, X Gen Medical LLC., was essential in order to allow Proteonomix to properly enter these global markets with the intention of soliciting business through our proprietary PRTMI model. We anticipate closing on some of these negotiations in the near future, which we anticipate will include the necessary funding required to firmly establish X Gen Medical as a PRTMI provider.”

About Proteonomix, Inc.:

Proteonomix is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging skin care products. StromaCel, Inc.’s goal is the development therapeutic modalities for the treatment of Cardiovascular Disease (CVD). StromaCel, Inc. is pursuing the licensing of other technologies for therapeutic use. National Stem Cell, Inc. is Proteonomix’s operating subsidiary. The Sperm Bank of New York, Inc. is a fully operational tissue bank. Proteonomix Regenerative Translational Medicine Institute, Inc. (“PRTMI”) intends to focus on the translation of promising research in stem cell biology and cellular therapy to clinical applications of regenerative medicine. Proteonomix intends to create and dedicate a subsidiary to each of its technologies. Please also visit http://www.proteonomix.com/, http://www.proteoderm.com/, http://www.otcqb.com/ and http://www.sec.gov/.

Forward-looking statements:
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Proteonomix, Inc. cautions that statements made in this press release constitute forward-looking statements and makes no guarantee of future performance. Actual results or developments may differ materially from projections. Forward-looking statements are based on estimates and opinions of management at the time statements are made.

Click here to see all recent news from this company

VICTORIA, BRITISH COLUMBIA–(Marketwire – Aug. 3, 2010) – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm” or the “Company”) today announced that it has entered into a loan agreement and general security agreement with MD Primer Inc. (“MDP”) under which MDP has agreed to extend to CardioComm a $200,000 line of credit secured against CardioComm’s assets, which CardioComm may use on an as-needed basis as it continues to implement its 2010/2011 business strategies. Any amounts drawn by CardioComm on the line of credit will bear simple interest at 6% per year and will be repayable on or before July 28, 2012. MDP is under the direction of Dr. Anatoly Langer, CardioComm’s Chairman. As MDP is a related party of CardioComm, Dr. Langer abstained from voting on the transaction when the transaction received board approval.

CardioComm also announced an amendment to its GEMS 4.0 software development agreement with MDP, dated November 1, 2009 and announced in a November 16, 2009 press release, involving the development and release of a new, multi -language compatible software platform of the GlobalCardio™, GEMS™ GEMS™ Air/HL7/Auto Attendant modules and other pipeline software systems. CardioComm was resticted to a five year time frame to purchase exclusive software rights. The amendment removes CardioComm’s purchase restriction clause, while continuing CardioComm’s perpetual, non-exclusive license to the software.

“With this amendment, we remain on track for our most significant software release which will keep us in step with emerging wireless technologies, and expansion into international markets. In addition, CardioComm is able to review its co-license agreement with MDP at its discretion,” reports Etienne Grima, CardioComm’s CEO.

The Company also announced that it granted an aggregate of 750,000 incentive stock options pursuant to its Omnibus Share Compensation Plan as follows: 500,000 options were granted to Etienne Grima, the Company’s CEO; and 250,000 options were granted to Wendy Hsieh, the Company’s CFO. The options are exercisable at $0.10 per share for five years from the date of grant, will vest equally over a period of 18 months and are subject to a four month hold period. The grant of options will be subject to the provisions of the Company’s Omnibus Share Compensation Plan, the policies of the TSX Venture Exchange and applicable securities laws.

About CardioComm Solutions, Inc.

CardioComm’s patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (EKGs), for diagnosis and management of cardiac patients. The Company’s products are sold worldwide through a combination of its external distribution network and its North American based sales team. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time EKG viewer. CardioComm is the first company to provide a real-time means of viewing EKGs over a network (LAN, WAN or Internet). This tool enables EKGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global EKG Management System (GEMS™) and GlobalCardio™. CardioComm’s software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.

On behalf of the Board of Directors of CardioComm Solutions, Inc.

Anatoly Langer, Chairman of the Board

SEATTLE, WA–(Marketwire – August 3, 2010) –  Mindbloom, Inc. today announced a strategic partnership with Sacramento State ‘s health and wellness facility, also known as The WELL (Wellness, Education, Leisure, Lifestyle), that will leverage Mindbloom technology to enhance the effectiveness of the campus’ 7 Dimensions of Wellness Program. 

The Well serves approximately 28,000 faculty, staff and students and is designed to support health-promoting behaviors and healthy life-balance choices. Mindbloom’s enterprise platform enables The WELL to insert its proprietary content into the Mindbloom platform to create a customized experience that encourages users to make their healthy behaviors an everyday priority.

“The WELL’s program is a perfect fit for our enterprise platform,” said Chris Hewett, Mindbloom’s founder and executive producer. “By fusing great content within an easy-to-use format, we’ve created a wellness and personal development experience that’s simple, fun and effective. The combination of the university’s framework and our Life Game™ platform will deeply engage students, faculty and staff in ways that can actually establish and sustain healthy habits.” 

Mindbloom.com is a social Life Game — a new genre of online experiences that motivate and activate people in their quest for health and wellness, life balance and meaningful relationships. By combining proven personal development concepts with gaming mechanics and social networking support, Mindbloom creates an immersive, personalized, online experience where users choose and accomplish small steps that produce meaningful results. Its enterprise platform allows content providers, wellness programs, and health-oriented communities to embed the Mindbloom experience into their own website, customize their users’ experience, incorporate their proprietary content, and extend both their core philosophy and their brand.

“Incorporating the Mindbloom enterprise platform takes our 7 Dimensions of Wellness Program to a higher level,” said Mirjana Gavric, director of The WELL. “It helps us personalize our information and its experiential engagement and social networking support make it a perfect fit for the members of the Sacramento State community.”

Mindbloom Launches Enterprise Platform

The WELL at Sacramento State is a 151,000-square-foot-facility that’s scheduled to open September 2, 2010. Its 7 Dimensions of Wellness Program helps participants explore and balance all aspects of their lives, toward creating and maintaining optimal wellness. 

“Mindbloom’s enterprise platform is an important part of our business model,” said Brent Poole, Mindbloom’s CEO. “Partnering with academically grounded and well developed programs like The 7 Dimensions of Wellness allows us to connect with people who have decided they want to take more responsibility for their own health, and who want a little extra help to take small steps toward things that they care about.” 

Because the Mindbloom experience is effective in motivating and supporting people to make and sustain personal change, Mindbloom’s enterprise platform will be attractive to any company, association, organization, or community seeking to support its members to make personal change toward healthier lifestyles. It is an excellent business solution for corporate wellness companies, employee benefit departments, health systems, insurance networks, and wellness programs. 

About Mindbloom

Mindbloom, Inc. is located in Seattle, Wash. and was founded in 2008. The company provides an online service, The Mindbloom Life Game™, which offers an interactive, fun and rewarding way to focus priorities around health and wellness. The service includes components of casual gaming, social networking and personal media sharing. It was built by former executives and developers from Amazon, Monolith, AOL, Microsoft, Vulcan and Adobe. Users have found Mindbloom to be an effective way to manage personal intentions and goal setting. The mission of the company and the game itself is to inspire and motivate people to live a healthy, balanced and meaningful life. Mindbloom offers a free-to-play version which requires the user to “earn” their way through the experience and a Professional version in which users are able to add content (actions, images, goals) at will. There are currently two subscription levels for this service priced at $39/year or $89 for a lifetime. Mindbloom also offers completely customized and white-label solutions for enterprise organizations. For more information, please visit www.mindbloom.com

About The WELL at California State University, Sacramento

The WELL will be a 151,000-square-foot multi-use facility with multi-activity courts, weight and fitness rooms, climbing wall, indoor track, and a new student health center. Sacramento State students will be able to exercise, participate in group recreational activities, access healthcare services, study and socialize. The WELL mission statement, “Lifetime wellness through collaboration, education and innovation sets the tone for a renewed and vibrant campus life. It will also be a resource for faculty and staff as it offers a host of cutting-edge fitness, recreation, and athletic opportunities. For more information about The WELL, please visit http://www.thewell.csus.edu/

LIVINGSTON, NJ–(Marketwire – August 3, 2010) –  A newly published report underscores the importance of technology and skilled technique in the practice of preimplantation genetic diagnosis (PGD). PGD has been a hotly debated topic in recent years due to the inconsistent conclusions from numerous trials.

Downloadable photos and other supporting materials available here: http://www.multimedianewscenter.com/reprogenetics/new-report-bolsters-support-for-pgd

The paper, published in the July issue of Fertility and Sterility, identifies numerous factors that contribute to the procedure’s success. Data show that PGD success appears to correlate with access to the appropriate technology and the level of skill and technique used by the embryologists.

“Our analysis of available research shows that clinics using optimal methodology, highly skilled technicians and the most advanced chromosomal assessment techniques have consistently shown an improvement in assisted reproductive technology results with PGD,” said Santiago Munné, Ph.D., founder of Reprogenetics and one of the nation’s leading experts on PGD. “PGD remains a viable option for many couples who are at risk of passing on certain genetic diseases to their children or who have been unsuccessful with assisted reproduction to help increase their chance of having a healthy baby.”

In his review, Dr. Munné identified that widely varying biopsy and chromosome analysis procedures were used, leading to conflicting results. Additionally, poor training and limited experience in these delicate procedures may also contribute to reduced embryo implantation following PGD.

According to Dr. Munné, the formula for successful PGD includes: Identifying the appropriate patient by considering maternal age and evaluating the number of embryos available, using an experienced laboratory with trained scientists reduces the risk of not obtaining a result, taking a biopsy of a single cell from the embryo, processing of the cell appropriately, analyzing a minimum of eight important chromosomes as well as working with a PGD laboratory that has an error rates below 10% with extensive experience and showing positive outcomes in PGD. 

The technique used to analyze the extracted chromosomes may play an important role in embryo selection. Array comparative genome hybridization (array CGH) is a newer technique capable of accurately determining total or partial abnormalities affecting any of the 24 different types of chromosomes, compared to more traditional FISH testing which analyzes just 5-12 chromosomes. Data presented at the last American Society of Reproductive Medicine meeting demonstrated that using CGH analysis resulted in a highly statistically significant increase in implantation rates in women with an average age of 38 and with one to 10 prior failed IVF cycles.

About PGD
In PGD, embryos created through in-vitro fertilization are tested for chromosomal abnormalities prior to replacement in a woman’s uterus. This process allows the reproductive endocrinologist to select only chromosomally healthy embryos for replacement with the goal of increasing the chance of successful implantation, reducing spontaneous abortion, reducing the chance for a fetus to have a chromosomal abnormality and in some cases improving delivery rates for assisted reproduction.

Chromosome abnormalities are the primary cause of miscarriage and more than 50%. This percentage increases with maternal age, and studies have shown that 82% of embryos from woman 40 years and older will be chromosomally abnormal.

About Reprogenetics
Reprogenetics is a private genetics laboratory specializing in Preimplantation Genetic Diagnosis (PGD). Dr. Santiago Munné and Dr. Jacques Cohen founded Reprogenetics in the year 2000 after extensive experience in PGD and IVF. Reprogenetics offers a comprehensive and personalized service to its referring IVF centers and their patients. Genetic counselors are intricately involved in the process and interact routinely with the patients pursuing all PGD tests. 

WAYNE, PA–(Marketwire – July 29, 2010) –  Clinical and Laboratory Standards Institute (CLSI) unveiled the release of StatisPro^™, its new method evaluation software package for the evaluation, verification, and validation of performance characteristics of laboratory test methods at the AACC/ASCLS Annual Meeting this week.

StatisPro software delivers a feature-rich tool designed to perform the statistical analysis necessary to meet regulatory and accreditation requirements. Hospitals, physician office laboratories, reference laboratories, and customer support departments of in vitro diagnostic manufacturers can benefit from using this new method evaluation software.

David Grenache, PhD, DABCC, FACB, Associate Professor, Department of Pathology, University of Utah, ARUP Laboratories, and beta-tester for StatisPro, says, “The benefits of StatisPro are its ease-of-use and intuitive interface. When validating a new method, replacing equipment, or preparing for accreditation or regulatory inspections, StatisPro makes advanced statistical analysis easier regardless of the size of the laboratory using it.”

Developed in conjunction with Analyse-it^®, StatisPro can produce reports on analytical accuracy, precision, linearity, limit of detection and quantitation, and reference intervals and is entirely based on the most up-to-date CLSI guidelines.

With StatisPro, laboratories can:

• Verify comparability of new methods and systems.
• Ensure comparable results across measuring systems.
• Establish reference intervals or transfer intervals between methods and laboratories.

James Huntington, Co-founder, Analyse-it^®, describes the importance of evaluating and verifying method performance, saying, “Laboratories must ensure method performance is as expected to meet regulatory or accreditation requirements. As the statistics necessary to determine method performance become more complex, software such as StatisPro is essential to ensure accurate, correct, determination of method performance.”

CLSI partnered with Analyse-it because of its excellent reputation and proven experience in creating statistically based software, as well as its similar culture and values to CLSI, explains Glen Fine, MS, MBA, CAE, CLSI Executive Vice President. “Since StatisPro is based on CLSI’s world-renowned best practices, it will inspire user confidence. This is the only software package available that streamlines implementation of CLSI’s latest method evaluation guidelines. StatisPro allows staff of laboratories of any size to produce advanced statistical calculations and display reports quickly and accurately in order to ensure the highest quality patient care,” says Fine. 

StatisPro is available directly from CLSI. For more information, please visit www.StatisPro.org or call 877.477.1888.

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information visit the CLSI website at www.clsi.org or call 610.688.0100.

Analyse-it Software, Ltd. formed in 1997 to develop statistical analysis and charting software for Microsoft^® Excel^™, and built its flagship product, Analyse-it, through work with some of the world’s largest in vitro diagnostic companies. Now with more than 20,000 customers, Analyse-it is highly respected in the scientific and research community, and is used and cited in thousands of peer-reviewed published papers. For additional information, visit the Analyse-it website at www.analyse-it.com.

Click here to see all recent news from this company

SALT LAKE CITY, UT–(Marketwire – July 28, 2010) –  AdvancedMD^® Software, Inc., the leader in all-in-one, web-based practice management, electronic health record (EHR), and billing applications for medical practices and medical billing services, today announced that PhySource Solutions, Inc., an AdvancedMD AdvancedBiller^® partner, has achieved two significant milestones in client service and company growth. On average, over the past 12 months the company’s new clients have reduced outstanding accounts receivable balances considered uncollectible from 30% to 2%. This caliber of results has fueled more than 100% growth in the company’s client list over the past year.

With the prolonged economic downturn, PhySource Solutions has seen many medical group clients struggle to keep accounts receivable within acceptable limits. Typical new clients have more than 30% of their receivables in the 90-day or greater category, which is considered mostly uncollectible. After only six months with PhySource Solutions, new medical practice clients see accounts receivable numbers come into line with MGMA industry benchmarks. PhySource clients realize on average 80% of claims in the current category (within 30 days) and only 10% at 90 days or more.

“Bringing accounts receivable in line is an exciting thing for clients, particularly when they see the impact it can have on revenues and profitability,” said Zina Kacha, director of business relations for PhySource Solutions. “In a scenario like this, clients regularly see at least a 15 percent improvement in revenues and profits.” PhySource founders Patricia Rosbrook and Kacha each have more than 25 years of experience in medical billing, financial analysis, consulting and executive management in a variety of healthcare related companies.

Largely as a result of the magnitude of payment improvement PhySource regularly achieves for clients, the company recently signed a new contract to provide billing services to San Diego Heart and Vascular, a seven provider Cardiology group serving the San Diego region. “The number one reason we switched [to PhySource Solutions] was that Dr. Salami’s trial EOB reports came in showing line after line of ‘paid’ instead of the multiple zeros we saw under the previous system,” said Mary Augenbaugh, practice administrator for San Diego Heart and Vascular.

As a participant in the AdvancedBiller partner network, PhySource Solutions runs its revenue management service on the AdvancedMD Software-as-a-Service platform, featuring a continuously updated payer rules engine, connectivity to more than 1,400 payers and instant software updates. In a large measure due to these AdvancedMD automation tools for claims management and the system’s robust reporting capabilities, PhySource was able to double its business last year and expects to double again next year. By avoiding stacks of paper, unwieldy filing systems, and tedious work in tracking down details, the firm has built a highly effective claims management system that can be quickly scaled up to handle the significant growth PhySource is experiencing.

“AdvancedMD is quality backed by functionality that equals manageability,” said Kacha. “It allows us to compile, maintain and track the mountains of data endemic to our industry in a way that I’ve never seen before. It’s the WOW of medical billing software.”

“AdvancedMD has made a corporate commitment that we will not compete with our billing service provider customers,” said Bill Stone, vice president and general manager of AdvancedMD Billing Services Partner Division. “Our relationship with PhySource Solutions is a prime example of this philosophy in action. We couldn’t be more pleased with their growth and success, and we remain committed to helping them grow their client base.” The AdvancedBiller program not only provides medical billing services with a leading technology platform, it provides lead generation opportunities to partners and sales support to help the billing service accelerate sales.

AdvancedMD Resources

• Learn more about PhySource Solutions: http://advancedmd.com/resources/medical-billing-software-case-study/
• Learn about the AdvancedBiller program: www.advancedbiller.com
• Learn about SaaS-based medical office software

About PhySource Solutions, Inc.

PhySource Solutions is a dynamic company located in San Diego, California. PhySource Solutions uses extensive surgical coding and medical billing knowledge to deliver comprehensive Revenue Cycle Management Services to its providers. The company has deep specialty specific experience and proficiencies for cardiology surgeon groups, helping their providers optimize their bottom line by providing a fully integrated Revenue Cycle Management service that includes surgical coding, medical billing, front-end training and financial analysis and reports. For more information, please visit www.physourcesolutions.com.

About AdvancedMD Software

AdvancedMD provides a market leading Software-as-a-Service (SaaS) electronic health record (EHR) and practice management (PM) software platform delivered to more than 10,000 providers and 300 medical billing service providers nationwide. As a complete Medical Practice Optimization solution, the product combines the clinical with the financial to improve workflow and revenue capture. The AdvancedMD solution includes a certified EHR, patient portal, scheduling, electronic eligibility verification, electronic prescribing, and mobile access capabilities for the practice. It provides sophisticated, efficient claims processing, denial tracking and revenue management for the billing professional. Processing more than 1M claims per month through its clearinghouse, the company is able to identify payer rule changes quickly and continuously adjust the software to reflect those changes, yielding first-pass claim acceptance rates of 95 percent or better, compared to the national average of 70 percent. For more information, please visit www.advancedmd.com.

*AdvancedBiller is a registered trademark of AdvancedMD

IRVINE, CA–(Marketwire – July 28, 2010) –  Lantronix, Inc. (NASDAQ: LTRX), a leading provider of secure, remote management, device networking and data center management technologies, today announced the worldwide availability of the EDS1100 and EDS2100 Linux software development kit (SDK), furthering its commitment to Linux and strategy for open source computing. The new SDK allows Linux developers to quickly and easily create value-added applications on the EDS1100/2100. Built on the proven, stable 2.6 Linux kernel, the SDK includes a robust set of components for building secure network-enabled products and applications using Linux, one of the world’s most popular open operating systems. Also included in the announcement are firmware updates for the XPort® Pro Linux SDK and MatchPort® AR Linux SDK, available for download at www.Lantronix.com/downloads. 

The EDS1100 and EDS2100 Linux SDK key improvements include:

• uClinux baseline upgrade (Linux kernel 2.6.29);
• IPv6-ready Certification;
• SDK VMWare VM Image to enable developers to build, deploy, customize and maintain Linux applications in a Windows environment;
• Serial-to-Ethernet with SSL and SSH support sample application.

“While we will continue to offer our customers the tools to develop products using our tried and true operating systems, expanding our Linux offerings extends the capabilities of our products for current customer needs and opens up our products to an exponentially wider audience,” said Daryl Miller vice president of engineering for Lantronix. “Every new product we launch will now support Linux.”

The EDS1100/2100 is also available with Lantronix’ powerful operating system, Evolution OS®, which provides end-users a rich, turnkey option with robust functionality right out of the box.

About EDS1100/2100
The EDS1100 and EDS2100 are unique, hybrid Ethernet terminal/multiport device servers which allow remote access to and management of virtually any IT/networking equipment or edge device such as medical equipment, POS terminals or security equipment. Available with Linux and IPv6 or Lantronix’ powerful Evolution OS, the EDS1100/2100 is the best choice when critical data needs to be remotely and securely accessed anywhere, at any time, via the Internet.

For more details on EDS1100/2100, please visit http://www.lantronix.com/device-networking/external-device-servers/eds1100_eds2100.html or contact [email protected].

The Lantronix blog, http://www.lantronix.com/blog, features industry discussion and updates. To follow Lantronix on Twitter, visit http://www.twitter.com/Lantronix

To receive an RSS feed of all Lantronix’ news, please visit http://www.lewiswire.com/us/lewiswire/Lantronix/c/458 and click on subscribe.

About Lantronix
Lantronix, Inc. (NASDAQ: LTRX) is a global leader of secure communication technologies that simplify remote access, management and control of any electronic device. Its solutions empower businesses to make better decisions based on real-time information, and gain a competitive advantage by generating new revenue streams, improving productivity and increasing efficiency and profitability. Easy to integrate and deploy, Lantronix products remotely connect and control electronic equipment via the Internet; provide secure remote access to firewall-protected equipment; and enable remote management of IT equipment over the Internet. Founded in 1989, Lantronix serves some of the largest security, industrial and building automation, medical, transportation, retail/POS, financial, government, consumer electronics/appliances, IT/data center and pro-AV/signage entities in the world. The company’s headquarters are located in Irvine, Calif. For more information, visit www.lantronix.com.

SAUNDERSTOWN, RI–(Marketwire – July 20, 2010) – For the small practice healthcare provider, selecting an Electronic Health Record (EHR) system can be a daunting task, with more than 300 vendors, complicated pricing, and products that are impossible to evaluate for usability, effectiveness, and implementation times. Oftentimes this leads to buyer’s remorse and later switching to another EHR.

Due to its industry-leading user satisfaction ratings in multiple studies, $995 price tag, and three month risk-free trial offer, Amazing Charts has quickly emerged as the EHR-of-choice for small practices.

Founded and designed by physician Jonathan Bertman, MD, FAAFP, specifically for offices with three or fewer providers, Amazing Charts enables rapid documentation of patient encounters, with fewer errors, faster coding, and ePrescribing. In most cases, no training is required for first-time users. Amazing Charts is a CCHIT Certified® 2008 Ambulatory EHR additionally certified for Child Health.

Gordon Comstock, MD, practices family and geriatric medicine in Arcade, New York, a low-income area of the state. His medical practice has over 3,000 patients, many of who are elderly and on fixed incomes.

At his former practice, Dr. Comstock saw his colleagues “spend nearly $280,000 on an EHR system they found to be unwieldy and difficult to use.” He notes that there were way too many little pull-down menus and data fields, forcing him to “dictate notes anyway because [he] couldn’t document notes during a visit.” Additionally, the practice had to hire a full-time person just to scan paper documents like referral letters and lab reports into the EHR.

Today he uses Amazing Charts to run his entire office.

Says Dr. Comstock, “Amazing Charts is the closest an EHR can get to how a family doctor likes to generate a note. Many of the referral letters I see from specialists are indecipherable because they are generated by EHRs that don’t communicate what the specialist actually saw and thought. Amazing Charts always allows me to express myself in a way that captures not only the data points, but also the subjective narrative of my thoughts and observations.”

Another practice, Community Medical Group in Downey, California, had a different set of problems. After decades in operation, the three physician practice had amassed over 7,200 patients and their charts had become a significant obstacle to keeping the office running.

According to Dr. Martin Sechrist, “specific charts were hard to track down, the filing backlog was lengthy, and it was often difficult to match charts with filings.” 

With Amazing Charts, every patient has an electronic health record that can be accessed from any computer in the office, remotely, or via a simple iPhone app.

Says Dr. Sechrist, “Amazing Charts mirrors the way we conduct patient encounters, and makes immediately available all patient demographics, imported items, and a patient summary of current issues, medications, and prior encounters. Even outside laboratory results are imported directly into the electronic medical record!”

Amazing Charts automatically generates an electronic “super-bill” whenever a note is signed, and records are backed up daily in a secured database on-site.

Amazing Charts V5 can be downloaded for a free, three-month trial at http://www.amazingcharts.com.

About Amazing Charts
AmazingCharts.com provides Electronic Health Record (EMR) software and services to small and medium sized healthcare practices. Used by more than 3,600 practices in the U.S., Amazing Charts has been growing by over 70 new practices each month, based on its high ratings for quality, price, support, ease of use, and impact on productivity. For more information visit www.amazingcharts.com or call 1-866-382-5932.

Click here to see all recent news from this company

TAMPA, FL–(Marketwire – July 19, 2010) – Zimek Technologies (www.zimek.com) today announced the formation of the Zimek Global Health Foundation, a 501-C-3 non-profit organization, created to focus public awareness of increasing infection rates and bacteria becoming resistant to antibiotic drugs, according to Jen Grosman, President of the Board of Directors for the Foundation.

The Zimek Global Health Foundation will conduct infection control medical peer reviews on reducing infection rates utilizing Zimek’s automatic touchless decontamination systems, lab testing, pilot case studies, infection control technology research and development, as well as distribute Zimek decontamination systems to underprivileged population centers and disaster stricken areas across America and internationally. Zimek Global Health Foundation will seek out partnerships with key non-profit, emergency and charitable organizations to coordinate distribution of Zimek’s infection control technology.

“As President of the Board of Directors for Zimek’s Global Health Foundation, we are extremely excited to create meaningful public awareness for the need of life-saving infection control technology and to continue our important research and development capabilities to prevent the spread of infectious diseases,” said Jen Grosman.

Zimek Technologies (www.zimek.com), based in Tampa, Florida, has been developing and marketing its patented automatic Micro-Mist™ decontamination technologies for more than five years. Zimek’s industry-leading technologies are used by the U.S. Department of Homeland Security, Fire and EMS departments, healthcare facilities, public health agencies, transit systems, correctional facilities and local law enforcement agencies across America.

SAN FRANCISCO, CA–(Marketwire – July 15, 2010) –  With the innovative use of several emerging technologies, San Francisco-based digital healthcare agency Eveo made a big impression at the 2010 ASCO trade show. The 46th Annual meeting of the American Society of Clinical Oncology (ASCO) was held in Chicago, June 4-8, 2010, where more than 30,000 oncology specialists from around the world gathered to discuss the latest innovations in research, quality, practice and technology in cancer. Eveo (www.eveo.com) partnered with marketers to create customized, engaging programs that improved the overall quality of customer interactions and led to a dramatic increase in booth traffic.

Eveo’s Stereoscopic 3D Animation Video was viewed by over 1,000 participants at ASCO. In addition, the multi-touch technology and “Build a Patient” program were showstoppers as they deepened customer engagement and improved retention. Eveo also released several new applications for the iPhone and iPad that enabled health care providers to stay connected with their customers in a whole new way. “We knew the technologies we had in place were going to be a hit at ASCO,” says Eveo CEO and founder Olivier Zitoun, “but we didn’t expect the reaction to be as big as it was. The traffic in the booths was remarkable.”

Ensuring success at trade shows is no easy task. To maximize the potential for success, Eveo recommends following these simple best practices:

1. Start planning for the launch of new technologies early in the booth planning process. The more time you spend up front, the more smoothly everything will go.
2. Perform live technology testing for new programs as part of the booth planning and set up process. This is often overlooked, but an important key to success.
3. Train reps and booth personnel on new technologies prior to the show. Reps should be focused on demonstrating exciting new technologies, not learning them as they go.
4. Optimize booth staffing by utilizing reporting and tracking for all show displays.
5. Send post-conference surveys to customers and corporate participants to learn about what worked and what didn’t.
6. Make sure there are clear signs and directions for each display, especially if it is a new technology.
7. To maximize ROI, develop programs that reps can use in the field after the show or health care providers can access digitally and/or via mobile devices. 

To enlist Eveo’s help in your next tradeshow, contact [email protected]. For a full list of Eveo’s services, visit http://eveo.com/what-we-do/.

ABOUT EVEO
For innovative e-marketing strategies and powerful digital solutions, many of the world’s leading pharmaceutical, biotech and medical device companies depend on Eveo, a full-service independent digital healthcare agency headquartered in San Francisco. Founded in1999, Eveo is led by CEO Olivier Zitoun and a seasoned management team with extensive backgrounds in healthcare and interactive. Eveo’s core capabilities encompass all facets of digital marketing, as well as non-traditional web solutions, video production, 3D animation, tradeshow solutions, mobile applications, multi-touch experiences and more. The agency has a staff of over 150, with field offices in Chicago, New York, New Jersey and Philadelphia. Over the course of its ten years in business, Eveo has collected over 70 industry awards and in 2010 was named the #1 Independent Digital Healthcare Agency in the U.S. (based on 2010 Agency List ranking agencies by revenue). Eveo is redefining the e in e-marketing. Visit: www.eveo.com